Co-expression of Snail and excision repair cross-complementing group 1 (ERCC1) in head and neck squamous cell carcinoma (HNSCC) patients correlated with cisplatin resistance and poor prognosis (Hsu et al. 2010). The gene discussed is ERCC1; the disease is head and neck squamous cell carcinoma.